HuBit Genomix KK is a Japanese company located in Tokyo specializing in commercial physical and biological research. Celera Group acquired HuBit Genomix KK on March 20, 2001.

National Center for Child Health and Development consists of a children’s hospital that conducts medical scientific research.

Chang Gung Biotechnology is a Taiwanese private company located in Taipei that manufactures and retails herbal & dietary supplements.

Hangzhou Zhejiang University Dixun Bio-Gene Engineering Co., Ltd., established on 2003-12-05, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of plastic products;Sales of packaging materials and products;Instrument sales;electronics sales;Wholesale of electronic components;Non-residential real estate leases;Medical equipment rental;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Wholesale medical masks;daily mask(non-medical)Sales;internet sales(Except for products that require a license for sale);Glass fiber and product manufacturing;Glass fiber and product sales;Paper Products Manufacturing;Paper Products Sales;Instrument Manufacturing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shaoxing Medikang Biotechnology Co., Ltd., established on 2006-07-17, Business scope includes research and development,Production:third category6840In vitro diagnostic reagents,second category6840In vitro diagnostic reagents,second category6840Clinical Laboratory Analytical Instruments,second category6870Diagnostic image processing software,the first sort6840In vitro diagnostic reagents;Sell ​​self-produced products.

Jinan Deheng Medical Technology Co., Ltd., established on 2012-09-10, The scope of business includes the production of medical devices,Sales;Import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangsu Haooubo Biomedical Co., Ltd., established on 2009-06-08, Business scope includes a,two,Three types of in vitro diagnostic reagents,Production of Class II medical device software;one,two,Class III Medical Devices(Contains in vitro diagnostic reagents,No implants)promotion of,import and export,commission agent(except auction)and related business(Operate according to the approved scope of the license),Sell ​​self-produced products;one,two,Class III Medical Devices,Technical research and development of medical device software,technical consulting,Technical Services,technology transfer.Own house rental.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

MD Healthcare, Inc. is engaged in developing innovative precision medical solutions based on micro biome data. The company was founded in January, 2014 and is headquartered in Seoul, South Korea.

Biominda Biological Technology provides animal disease detection and related production services. It also offers biological testing, pathological testing, allergen screening, stone composition analysis, endocrine testing, biochemical testing, genetic testing, and many other customized services. They serve molecular medicines for pet doctors, breeding owners, and other related units or individuals.

Ruijie Biotechnology Jiangsu Co., Ltd., established on 2016-09-29, The scope of business includes engaging in biomedicine(Does not contain human stem cells,Development and application of genetic diagnosis and treatment technology),Medical device research and development,technical consulting,technology transfer;Medical device production,Sales,Rental and Maintenance;Import and export of goods or technology,(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval),(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Jiangsu Fulong Biotechnology Co., Ltd., established on 2008-06-10, The business scope includes products in the field of life sciences,Central Nervous Kit(Nerve Detection Reagents,Rapid Golgi Staining Reagent,cell death reagent)Research,to develop;Food Safety Testing Reagents(Colloidal gold quick test card,ELISAReagent test kit)Research,to develop,Production,Sales;Research on In Vitro Diagnostic Reagents,to develop,Technical Services;Research on biotherapeutic technology,to develop,Serve;Production of food safety testing instruments,Sales;Class I medical device sales;Class II medical device sales;Class III medical device sales(according to<Medical Device Business License>Approved range sales);Class I medical device,Class II medical device,Technology research and development of three types of medical devices,Technical Services,technical consulting;Production of Class I Medical Devices,Production of Class II Medical Devices(according to<Medical device production license>Approved scope of production);Production of Class III Medical Devices(according to<Medical device production license>Approved scope of production);biomaterials(Dehazardous chemicals)promotion of;Self-operated and agent import and export business of various commodities and technologies,Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

Itea SpA provides high technology energy-recovery solutions. The firm offers combustion technologies review, solid treatment, coalescence, fumes and heavy metals treatment, process control software and gas analysis, and zero emission coal. The company is headquartered in Gallarate, Italy.

Dong-A Socio Holdings has been the leading pharmaceutical company in South Korea with its business focus in developing, manufacturing and distributing innovative products for the healthier life of their society. Headquartered in South Korea, Dong-A Pharm. employs over 2,300 people worldwide.

Biomay has assembled an impressive pipeline of innovative products for immunotherapy of allergic diseases based on its proprietary technology platforms. The IgE immune apheresis device IgEnio®, co-developed with Fresenius Medical Care, has achieved CE mark designation and is currently actively marketed in several European countries. Additional clinical studies are underway to broaden the scope of applications for this unique product. The most advanced peptide carrier fusion allergy vaccine BM32, indicated for grass pollen allergy, has completed phase IIb of clinical development and is ready for phase III pivotal Trials.

Tianjin Chinese Enterprise Huake Biotechnology Development Co., Ltd., established on 2008-10-23, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Medical Research and Experimental Development;Sales of plastic products;electronics sales;Wholesale of computer software, hardware and auxiliary equipment;Information Consulting Service(Not including licensing information consulting services);marketing planning;market survey(Does not include foreign investigations);Conference and Exhibition Services;Special Equipment Repair;Class II Medical Device Leasing;Food import and export;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;food sales;Food Internet Sales;Class III Medical Device Leasing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Sekisui Chemical Co., Ltd. engages in the manufacture of high-performance plastics for medical, automotive, and information technology industries; and residential housing construction. It operates through the following segments: Housing, Environment and Lifeline, High Performance Plastics, Medical, and Others. The Housing segment handles the construction, sale, and renovation of housing units. It also provides real estate and housing services. The Environment and Lifeline segment offers PVC pipes and fittings, pipe rehabilitation materials, reinforced plastic composite pipes, and synthetic wood. The High-Performance Plastics segment sells interlayer films for laminated glass, foamed polyolefin, tapes, fine particles for liquid crystals, photosensitive materials, and functional resins for infrastructure materials. The Medical segment covers clinical diagnostic reagents, clinical testing equipment, active pharmaceutical ingredients and intermediates. The Others segment covers film-type lithium-ion batteries. The company was founded on March 3, 1947 and is headquartered in Osaka, Japan.

Zhongnong Kangzheng Technology Service Co., Ltd., established on 2012-12-20, Business scope includes licensed projects:Certification Services;Inspection and testing service;Internet information service;Radio and television program production and management(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Biochemical product technology research and development;engage in language skills,Art,physical education,A profit-making private training service organization for science and technology training(In addition to the subject classes for primary and middle school students,Language and cultural education and training);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hunan Haooubo Biopharmaceutical Co., Ltd., established on 2021-01-08, Business scope includes medical research and experimental development;Class I medical device,Class II medical device,Research and development of three types of medical devices;Class I medical device,Class II medical device,Production of Class III Medical Devices;Class I medical device,Class II medical device,Sales of Class III Medical Devices;Medical device technology promotion service;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)